Abstract
Liver transplantation is a life-saving procedure for end-stage liver disease. In liver transplant recipients, morbid obesity influences post-operative survival and graft function. In 1996, our patient underwent a successful liver transplantation because of a HCV-related liver failure (body mass index (BMI) 31). Follow-up showed a functional graft and the development of severe obesity up to a BMI of 61 in January 2006. In January 2007, he was submitted to intragastric balloon therapy for 6 months, reaching a BMI of 54. In September 2007, he underwent a biliopancreatic diversion. During follow-up to March 2008, he reached a BMI of 42 with ameliorations of comorbidities. In May 2008, during a hospital admission, he suddenly died of a heart attack. Post mortem study revealed a myocardial infarction. This is the first world case report for this approach. According to our opinion, patient’s death was not related to bariatric surgery.
References
Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr. 2002;21(5):365–71.
Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.
Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005;15:310–5.
Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.
Butte JM, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation. Obes Surg. 2007;17(11):1517–9.
Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3(1):78–83.
Guedea ME, Arribas del Amo D, Solanas JA, et al. Results of biliopancreatic diversion after five years. Obes Surg. 2004;14(6):766–72.
Keeffe EB, Gettys C, Esquivel CO. Liver transplantation in patients with severe obesity. Transplantation. 1994;57:309.
Guckelberger O, Bechstein WO, Neuhaus R, et al. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. Clin Transpl. 1997;11:60.
Sawyer RG, Pelletier SJ, Pruett TL. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transpl. 1999;13:126.
Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation. 2001;72(1):156–9.
Everhart JE, Lombardero M, Lake JR, et al. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg. 1998;4:285.
Hibberd AD, Trevillian PR, Roger SD, et al. Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients. Transplantation. 2006;15(81):711–7.
Deogracias ML, Dominguez-Diez A, Palomar-Fontanet R, et al. Biliopancreatic diversion in a renal transplant patient. Obes Surg. 2007;17:553–5.
Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Med Sci. 2006;331(4):219–25.
Bianchi G, Marchesini G, Marzocchi R, et al. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl. 2008;14:1648–54.
Perkins JD. Influence of obesity with concurrent diseases on liver transplant survival. Liver Transpl. 2007;13:928–9.
Wang J, Zhang Z-R, Chou C-F, et al. Cyclosporine stimulates the renal epithelial sodium channel by elevating cholesterol. Am J Physiol Renal Physiol. 2009;296:F284–90.
Moreno Planas JM, Rubio Gonzales E, Herreros de Tejada A, et al. Late mortality in patients with liver transplantation: causes and risk factors. Transplant Proc. 2003;35:707–8.
Lukes DJ, Herlenius G, Rizell M, et al. Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience. Transplant Proc. 2006;38:2671–2.
Pan C, Jain A, Fung JJ. Analysis of causes of late mortality in liver transplant recipients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004;16:547.
Pruthi J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl. 2001;7(9):811–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gentileschi, P., Venza, M., Benavoli, D. et al. Intragastric Balloon Followed by Biliopancreatic Diversion in a Liver Transplant Recipient: A Case Report. OBES SURG 19, 1460–1463 (2009). https://doi.org/10.1007/s11695-009-9877-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-009-9877-8